CGON - CG Oncology Inc Company Long-Term Liabilities

Public company logo of CG Oncology Inc (CGON)

CG Oncology, Inc. (CGON) possesses significant market influence due to the inelastic demand for oncolytic developments, which, combined with treatment certifications, ensures stable multi-year revenue. The volume of the firm's long-term borrowings confirms this stability, as the value is maintained at 0.01. Current growth is supported by revolutionary immunotherapy that allows patients to avoid radical surgical organ removal.

cgoncology.com (CGON) Company Long-Term Debt: for the period 02/21/2024 - 11/01/2026

CG Oncology Corp (CGON) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price cgoncology.com|CGON - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation CG Oncology|CGON - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share CG Oncology|CGON - Company Book Value|Market Value to Book Value cgoncology.com|CGON - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio CG Oncology, Inc.|CGON - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio CG Oncology Therapeutics|CGON - Company Total Debt|Debts to Book Capitalization CG Oncology|CGON - Company Long-Term Debt|Company Short-Term Loans and Borrowings CG Oncology|Immediate Liquidity cgoncology.com
- earnings and market multiples details:
CGON - Net Profit
Fundamental company valuation:CGON (cgoncology.com)
Brand item of CG Oncology, Inc.

This indicator measures the total volume of liabilities with a maturity of more than one year, allowing for an assessment of the long-term credit burden and the stability of the capital structure. By analyzing the company's history of long-term borrowings, an investor sees the current value of 0.01, which is critically important for CG Oncology, Inc. (CGON), as the balance between debt and liquidity determines the biotech's ability to fund costly clinical trials and retain leading scientists.

Competitors of CG Oncology, Inc. (CGON)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt UroGen Pharma Corp (URGN)|Company Long-Term Debt Bicara Therapeutics Inc.|PSNL: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities ERAS (Erasca)|DCTH (Delcath Systems Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts YMAB (YmAbs)|AURA - Company Long-Term Liabilities|CADL: Company Long-Term Liabilities|ARAY - Company Long-Term Debts|sellaslifesciences.com (SLS) - Company Long-Term Debt|Actuate Therapeutics Inc. - Company Long-Term Loans and Borrowings|CTOR (Citius Oncology, Inc) - Company Long-Term Debts|Long-Term Debt TuHURA HURA|Company Long-Term Debts TARA|Company Long-Term Liabilities fatetherapeutics.com FATE|Company Long-Term Debts WHWK (Aadi Bioscience)|Long-Term Indebtedness TScan Therapeutics Inc|CSBR: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings XBIT (XBiotech Inc.)|cel-sci.com (CVM) - Company Long-Term Debt|Long-Term Debt ostherapies.com (OSTX)|Company Long-Term Debt Radiopharm Theranostics Limited|Company Long-Term Indebtedness ARTV (Artiva)|Company Long-Term Debts ANL|Company Long-Term Liabilities Veru Corporation VERU|Company Long-Term Debt Tempest Therapeutics TPST|Xilio Therapeutics Inc (XLO) - Long-Term Debt|RENB - Company Long-Term Debt|MURA: Company Long-Term Debt|kairospharma.com (KAPA) - Company Long-Term Debt|Long-Term Debt OnKure Therapeutics (OKUR)|GDTC (CytoMed Therapeutics Ltd) - Company Long-Term Debts|CRIS - Long-Term Indebtedness|Company Long-Term Liabilities APLM (Apollomics, Inc.)|THAR - Long-Term Debt|Advanced Biomed - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings GNPX|Calidi Bio - Company Long-Term Debts|Long-Term Debt Volume Sunshine Biopharma Inc. SBFM|xeneticbio.com (XBIO) - Company Long-Term Debt|Company Long-Term Indebtedness SLRX|PPBT (Purple Biotech Corp) - Company Long-Term Debts|Company Long-Term Liabilities AON (AONC)|Company Long-Term Liabilities BGNE (BeiGene, Ltd.)|Long-Term Debt Volume checkpointtx.com|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|ICAD - Company Long-Term Liabilities|Ikena - Company Long-Term Debts|Long-Term Indebtedness Notable Labs Corp (NTBL)|viracta.com (VIRX) - Company Long-Term Debt|Long-Term Debt morphosys.com (MOR)|Company Long-Term Debt NAYA Biosciences Inc.|Company Long-Term Indebtedness AAPGV (Ascentage Pharma Group International)